Sullivan Christopher Ryan

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sullivan Christopher Ryan's trades of Avalo Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
20.05
Quantity 31,031
Value US$622,221
Transaction date
Proposed sale
Price
19.94
Quantity 3,749
Value US$74,762
Transaction date
Proposed sale
Price
21.81
Quantity 18,606
Value US$405,797
Transaction date
Proposed sale
Price
16.26
Quantity 47,000
Value US$764,220
Transaction date
Proposed sale
Price
12.86
Quantity 16,915
Value US$217,527
Transaction date
Proposed sale
Price
14.93
Quantity 15,959
Value US$238,268
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-16
PlS Planned sale
96,897 +28.5%
471.31
US$1,162,085 		96,897 +28.5% 471.31 US$1,162,085
2026-09-11 2026-09-10
PlS Planned sale
71,656 +5.2%
188.36
US$3,455,060 		71,656 +5.2% 188.36 US$3,455,060
2026-08-19 2026-08-18
S Sale
22,305 -42.3%
234.75
US$2,086,862 		22,305 -42.3% 234.75 US$2,086,862
2026-08-18 2026-08-18
PrS Proposed sale
31,031
20.05
US$622,221 		31,031 20.05 US$622,221
2026-08-19 2026-08-17
S Sale
3,749 -8.6%
19.94
US$74,762 		3,749 -8.6% 19.94 US$74,762
2026-08-19 2026-08-17
PlS Planned sale
37,945 -46.5%
19.85
US$753,333 		37,945 -46.5% 19.85 US$753,333
2026-08-17 2026-08-17
PrS Proposed sale
70,709
19.59
US$1,385,189 		70,709 19.59 US$1,385,189
2026-08-17 2026-08-17
PrS Proposed sale
3,749
19.94
US$74,762 		3,749 19.94 US$74,762
2026-05-11 2026-05-07
PlS Planned sale
18,606 -97.8%
24.12
US$448,818 		18,606 -97.8% 24.12 US$448,818
2026-05-07 2026-05-07
PrS Proposed sale
18,606
21.81
US$405,797 		18,606 21.81 US$405,797
2026-05-07 2026-05-06
PlS Planned sale
8,900 -95.5%
22.57
US$200,913 		8,900 -95.5% 22.57 US$200,913
2026-05-07 2026-05-06
PlS Planned sale
9,219 -49.7%
21.37
US$197,008 		9,219 -49.7% 21.37 US$197,008
2026-05-07 2026-05-06
PlS Planned sale
2,700 -12.7%
20.76
US$56,052 		2,700 -12.7% 20.76 US$56,052
2026-05-07 2026-05-06
PlS Planned sale
12,347 -36.8%
19.28
US$238,093 		12,347 -36.8% 19.28 US$238,093
2026-05-07 2026-05-06
PlS Planned sale
13,834 -29.2%
18.55
US$256,655 		13,834 -29.2% 18.55 US$256,655
2026-05-06 2026-05-06
PrS Proposed sale
47,000
16.26
US$764,220 		47,000 16.26 US$764,220
2026-05-01 2026-04-30
PlS Planned sale
8,457 -95.2%
13.23
US$111,853 		8,457 -95.2% 13.23 US$111,853
2026-05-01 2026-04-29
PlS Planned sale
8,458 -48.8%
13.09
US$110,736 		8,458 -48.8% 13.09 US$110,736
2026-04-29 2026-04-29
PrS Proposed sale
16,915
12.86
US$217,527 		16,915 12.86 US$217,527
2026-04-03 2026-04-02
PlS Planned sale
1,780 -9.3%
17.57
US$31,270 		1,780 -9.3% 17.57 US$31,270
2026-04-03 2026-04-02
PlS Planned sale
6,200 -24.5%
17.02
US$105,553 		6,200 -24.5% 17.02 US$105,553
2026-04-03 2026-04-01
PlS Planned sale
7,479 -22.8%
16.83
US$125,841 		7,479 -22.8% 16.83 US$125,841
2026-04-03 2026-04-01
PlS Planned sale
500 -1.5%
15.86
US$7,929 		500 -1.5% 15.86 US$7,929
2026-04-01 2026-04-01
PrS Proposed sale
15,959
14.93
US$238,268 		15,959 14.93 US$238,268
2023-06-13 2023-06-09
PP Planned purchase
511 +68.0%
3.42
US$1,748 		511 +68.0% 3.42 US$1,748
2021-12-14 2021-12-10
PP Planned purchase
955 +11.9%
1.57
US$1,499 		955 +11.9% 1.57 US$1,499
2020-12-14 2020-12-10
PP Planned purchase
5,095 +172.5%
2.28
US$11,606 		5,095 +172.5% 2.28 US$11,606
2020-06-11 2020-06-10
PP Planned purchase
2,954 +inf%
2.28
US$6,729 		2,954 +inf% 2.28 US$6,729